Invion Ltd has released a press release.
Major Milestone towards Clinical Trials
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Invion
- Investor Presentation
- Photosoft Territory Expanded to South Korea for Cancer
- Appendix 4E and Preliminary Financial Report
- Expansion of Territory Rights to USA, Canada and Hong Kong
- INV043 Effective Against Anal Cancer SCC In Vitro
Later from Invion
- AGM Presentation
- Agreement with Dr.inB to develop Photosoft treatment for HPV
- INV043 With ICI Therapy Achieved 80% Tumour Control For ASCC
- Agreement with Major South Korean Pharma Group Hanlim
- Invion secures funding through an institutional placement
Follow Invion into a list and get an email when it puts out news.
Follow Invion